
Yes, says a new cost comparison of immediate colposcopy, HPV DNA testing, and conservative management in nearly 3,500 women over a 2-year period. The data are from ALTS?atypical squamous cells of undetermined significance [ASCUS] and low-grade squamous intraepithelial lesion [LSIL] Triage Study.